Journals / Turkish Journal of Urology / 2019 / Cilt: 45 - Sayı: 2

Validation of the Turkish version of the Wisconsin stone-quality of life questionnaire

Pages
118–123
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further clinical studies inTurkish settings would be useful to provide powerful data on sensitivity to change.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: We validated the Turkish version of the Wisconsin Stone-Quality of Life (WISQoL) questionnaire for male and female patients with kidney stones.Material and methods: The Turkish version of the WISQoL questionnaire was developed following a wellestablished multistep process.
📊
Key Findings & Data:A total of 84 patients with kidney stones completed the Turkish WISQoL questionnaire, including the other validated questionnaires as The Short Form Health Survey (SF-36 v2) and Beck'sDepression Inventory.
💡
Conclusion & Impact:Further clinical studies inTurkish settings would be useful to provide powerful data on sensitivity to change.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objective: We validated the Turkish version of the Wisconsin Stone-Quality of Life (WISQoL) questionnaire for male and female patients with kidney stones.Material and methods: The Turkish version of the WISQoL questionnaire was developed following a wellestablished multistep process. A total of 84 patients with kidney stones completed the Turkish WISQoL questionnaire, including the other validated questionnaires as The Short Form Health Survey (SF-36 v2) and Beck'sDepression Inventory. Patients completed questionnaires before percutaneous nephrolithotomy (PNL) surgeryas well as 2–4 weeks after surgery. Reliability was evaluated by internal consistency (tested by Cronbach’s alfa)and test-retest reliability between week 2 and 4 (tested by Spearman correlation). Domain structures were examined by interdomain correlations using Spearman correlation coefficient. Convergent validity was assessed bycorrelating the scores of general health domain to the SF-36 v2, and the scores of emotional impact domain tothe Beck's Depression Inventory questionnaire. Sensitivity to change was assessed by comparing scores beforeand after PNL surgery with the Wilcoxon signed rank test. Discriminant validity was evaluated by comparingthe results of patients 2 and 4 weeks after surgery with Wilcoxon-rank sum tests.Results: The Turkish version of the WISQoL demonstrates good internal consistency (Cronbach’s α=0.72-0.78) and test–retest reliability (p>0.05). Inter-domain associations within the WISQOL showed a substantial correlation between various WISQoL domains, indicating a high conceptual relationship between thedomains. Also, the Turkish version of the WISQoL showed convergent validity with the correspondingvalidated questionnaires (Spearman’s rho correlation coefficient=0.44-0.78). All domains of the WISQoLshowed significant sensitivity to change (p≤0.001).Conclusion: The Turkish version of the WISQoL is a generally reliable instrument that can be self-administered by Turkish patients with kidney stones in clinical and research settings. Further clinical studies inTurkish settings would be useful to provide powerful data on sensitivity to change.

🔖

Cite This Article

ATALAY, H. A., ÜLKE, V., CANAT, L., ÖZER, M., CAN, O., PENNISTON, K. L. (2019). Validation of the Turkish version of the Wisconsin stone-quality of life questionnaire. Turkish Journal of Urology, Cilt: 45 - Sayı: 2, 118–123. https://ajindex.com/articles/379682

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Kim SP, Karnes RJ, Nguyen PL, Ziegenfuss JY, Han LC, Thompson RH, et al. Clinical implementation of quality of life instruments and prediction tools for localized prostate cancer: results from a national survey of radiation oncologists and urologists. J Urol 2013;189:2092-8. [CrossRef] Feuerstein MA, Jacobs M, Piciocchi A, Bochner B, Pusic A, Fayers P et al. Quality of life and symptom assessment in randomized clinical trials of bladder cancer: A systematic review. Urol Oncol 2015;33:331-8. [CrossRef] Kartha G, Calle JC, Marchini GS, Monga M. Impact of stone disease: chronic kidney disease and quality of life. Urol Clin North Am 2013;40:135-47. [CrossRef] Wiebe S, Guyatt G, Weaver B, Matijevic S, Sidwell C. Comparative responsiveness of generic and specific quality-of life instruments. J Clin Epidemiol 2003;56:52-6. [CrossRef] Penniston KL, Antonelli JA, Viprakasit DP, Averch TD, Sivalingam S, Sur RL, et al. Validation and Reliability of the Wisconsin Stone Quality of Life Questionnaire. J Urol 2017;197:1280-8. [CrossRef] Zhao PT, Hoenig DM, Smith AD, Okeke Z. A Randomized Controlled Comparison of Nephrostomy Drainage vs Ureteral Stent Following Percutaneous Nephrolithotomy Using the Wisconsin Stone QOL. J Endourol 2016;30:1275-84. [CrossRef] Hutchinson A, Bentzen N, König-Zahn C. Cross-cultural health outcome assessment: a user’s guide. European Research Group on Health Outcomes, Ruinen 1996; pp. 182-98.
  2. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 2003;63:1817-23. [CrossRef] Hesse A, Brändle E, Wilbert D, Köhrmann KU, Alken P. Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. Eur Urol 2003;44:709-13. [CrossRef] Angell J, Bryant M, Tu H, Goodman M, Pattaras J, Ogan K. Association of depression and urolithiasis. Urology 2012;79:518- 25. [CrossRef] Trinchieri A CG, Segura JW, Khoury S, Pak CY, Preminger GM, Tolley D. Epidemiology, in Stone Disease, Eds. Health Publications: Paris. 2003; pp. 201-29.
  3. Bryant M, Angell J, Tu H, Goodman M, Pattaras J, Ogan K. Health related quality of life for stone formers. J Urol 2012;188:436-40. [CrossRef] Miyaoka R, Ortiz-Alvarado O, Kriedberg C, Alanee S, Chotikawanich E, Monga M. Correlation between stress and kidney stone disease. J Endourol 2012;26:551-5. [CrossRef]